Plain-English translation of NCT05538806 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that gathers real-world information about how the NovoTTF-200T System — a medical device that uses special electrical fields to slow cancer cell growth — works in patients with pleural mesothelioma. You would receive this treatment as part of your normal medical care, and researchers would collect data about how well the treatment works and any effects you experience. The goal is to understand how this device performs when used in routine clinical settings, not in a controlled research laboratory.
Pleural mesothelioma is a serious cancer, and doctors want to learn more about how this treatment performs in everyday practice to help improve care for future patients. By collecting real-world information, researchers can better understand whether this device is helpful and safe when used by doctors in their regular clinics.
You likely qualify if…
You likely don't qualify if…
You would receive the NovoTTF-200T System as your regular mesothelioma treatment according to your doctor's medical guidelines. Researchers would collect information about your treatment and health outcomes over time as part of this study. Your role is mainly to use the device as prescribed by your doctor while allowing your medical team to share your treatment data with the research team for analysis.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
Germany